Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience

Selective Use of Combination Therapy in Patients With Infliximab-resistant Inflammatory Bowel Disease: Data From a Tertiary Referral Center

(2016) Ambrogio Orlando et al.   Clinical Gastroenterology and Hepatology

Frequency of thiopurine methyltransferase mutation in patients of Mediterranean area with inflammatory bowel disease and autoimmune disorders

(2016) Angela Di Salvo et al.   DIGESTIVE AND LIVER DISEASE

The Selective Use of Combination Therapy in Patients with Inflammatory Bowel Disease Resistant to Anti-TNF: to Whom, How and How Long?

(2016) Fabio Salvatore Macaluso et al.   Journal of Crohns & Colitis

Anti-TNF Monotherapy for Crohn’s Disease: a 13-year Multicentre Experience

(2016) Laurent Peyrin-Biroulet et al.   Journal of Crohns & Colitis

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

(2016) Fernando Gomollón et al.   Journal of Crohns & Colitis

Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases—A Prospective Study on Incidence and Severity

(2015) Niels Teich et al.   Journal of Crohns & Colitis

Clinical predictors of thiopurine-related adverse events in Crohn's disease

(2015) Gordon W Moran   WORLD JOURNAL OF GASTROENTEROLOGY

Thiopurines and Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease: A Meta-analysis

(2014) Tine Jess et al.   Clinical Gastroenterology and Hepatology

Use of azathioprine in IBD: modern aspects of an old drug

(2014) Edouard Louis et al.   GUT

A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis

(2013) N. A. Kennedy et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Use of Azathioprine and the Risk of Cancer in Inflammatory Bowel Disease

(2013) Björn Pasternak et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Assessment of Thiopurine S-Methyltransferase Activity in Patients Prescribed Thiopurines: A Systematic Review

(2013) Ronald A. Booth et al.   ANNALS OF INTERNAL MEDICINE

Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

(2013) Remo Panaccione et al.   GASTROENTEROLOGY

Safety of Thiopurine Therapy in Inflammatory Bowel Disease

(2013) María Chaparro et al.   INFLAMMATORY BOWEL DISEASES

Use of Thiopurines and Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Diseases: A Meta-Analysis

(2013) Jianfeng Gong et al.   PLoS One

Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease

(2012) Shomron Ben–Horin et al.   Clinical Gastroenterology and Hepatology

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol

(2012) Melissa A. Smith et al.   Journal of Crohns & Colitis

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease

(2011) Cristina López-Martín et al.   Gastroenterologia y Hepatologia

Thiopurine treatment in inflammatory bowel disease: Response predictors, safety, and withdrawal in follow-up

(2011) Giuseppe Costantino et al.   Journal of Crohns & Colitis

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease

(2008) U. HINDORF et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A Review

(2008) Javier P. Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY